Correlation Between Skye Bioscience, and Black Diamond

Can any of the company-specific risk be diversified away by investing in both Skye Bioscience, and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skye Bioscience, and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Skye Bioscience, Common and Black Diamond Therapeutics, you can compare the effects of market volatilities on Skye Bioscience, and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skye Bioscience, with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skye Bioscience, and Black Diamond.

Diversification Opportunities for Skye Bioscience, and Black Diamond

0.24

Correlation Coefficient

Skye Bioscience,  Black Diamond

Modest diversification

The 3 months correlation between Skye and Black is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Skye Bioscience, Common and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Skye Bioscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skye Bioscience, Common are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Skye Bioscience, i.e., Skye Bioscience, and Black Diamond go up and down completely randomly.

Pair Corralation between Skye Bioscience, and Black Diamond

Given the investment horizon of 90 days Skye Bioscience, Common is expected to generate 0.84 times more return on investment than Black Diamond. However, Skye Bioscience, Common is 1.19 times less risky than Black Diamond. It trades about 0.04 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  375.00  in Skye Bioscience, Common on September 30, 2024 and sell it today you would lose (129.00) from holding Skye Bioscience, Common or give up 34.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Skye Bioscience, Common  vs.  Black Diamond Therapeutics

Skye Bioscience, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Skye Bioscience, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Black Diamond Therap

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Skye Bioscience, and Black Diamond

The main advantage of trading using opposite Skye Bioscience, and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skye Bioscience, position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.

The idea behind Skye Bioscience, Common and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.